1/ Today, Pfizer released a PRE-PRINT with 6 months of follow-up data for its phase 2/3 COVID vaccine trial:
medrxiv.org/content/10.110…
THE TAKEAWAY: 2 doses of the Pfizer vaccine are highly effective in preventing severe disease, hospitalization, & death out to 6 months.
medrxiv.org/content/10.110…
THE TAKEAWAY: 2 doses of the Pfizer vaccine are highly effective in preventing severe disease, hospitalization, & death out to 6 months.
2/ Pfizer saw no new safety issues between its 2-month and 6-month analyses.
This is consistent with what we've seen with every other vaccine. If people are going to have a side-effect from a vaccine, they'll have it within 2 months of getting vaccinated.
This is consistent with what we've seen with every other vaccine. If people are going to have a side-effect from a vaccine, they'll have it within 2 months of getting vaccinated.
3/ The Pfizer vaccine was over highly effective in preventing ANY SYMPTOMATIC INFECTION out to 6 months:
2 months 96%
2-4 months 90%
4-6 months 84%
2 months 96%
2-4 months 90%
4-6 months 84%
4/ Vaccine efficacy against severe disease and death were in the mid-high 90% out to at least 6 months.
Vaccine efficacy for severe COVID disease in South Africa was 100%. The Beta variant, which is the MOST immune-evading of the variants, is prevalent in South Africa.
Vaccine efficacy for severe COVID disease in South Africa was 100%. The Beta variant, which is the MOST immune-evading of the variants, is prevalent in South Africa.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
